Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedNov 04, 2025
DataAggregated Company Financials
Companies159
  • 7D-6.6%
  • 3M17.4%
  • 1Y-19.1%
  • YTD-10.4%

Over the last 7 days, the Healthcare Services industry has dropped 6.6%, driven by a pullback from UnitedHealth Group of 8.8%. On the other hand Cardinal Health is actually up 16%. Overall the industry is down 19% in 12 months. Looking forward, earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 04 Nov 2025US$883.9bUS$2.1tUS$35.5b20.7x24.9x0.4x
Thu, 02 Oct 2025US$902.0bUS$2.1tUS$49.3b21.2x18.3x0.4x
Sat, 30 Aug 2025US$847.2bUS$2.1tUS$49.3b21.5x17.2x0.4x
Mon, 28 Jul 2025US$790.0bUS$2.1tUS$50.8b19.8x15.5x0.4x
Wed, 25 Jun 2025US$875.8bUS$2.1tUS$52.7b22x16.6x0.4x
Fri, 23 May 2025US$873.2bUS$2.1tUS$52.4b17.8x16.7x0.4x
Sun, 20 Apr 2025US$956.8bUS$1.7tUS$49.4b23.1x19.4x0.6x
Tue, 18 Mar 2025US$988.5bUS$1.7tUS$41.5b23.9x23.8x0.6x
Thu, 13 Feb 2025US$1.0tUS$1.7tUS$41.1b23.7x25x0.6x
Sat, 11 Jan 2025US$1.0tUS$2.0tUS$42.2b21.6x24.6x0.5x
Mon, 09 Dec 2024US$1.1tUS$2.0tUS$41.4b23.9x26.3x0.6x
Wed, 06 Nov 2024US$1.1tUS$1.9tUS$44.0b24.2x25.3x0.6x
Fri, 04 Oct 2024US$1.2tUS$1.9tUS$43.3b24.5x27.5x0.6x
Sun, 01 Sep 2024US$1.2tUS$1.9tUS$43.3b26.6x28.3x0.6x
Tue, 30 Jul 2024US$1.2tUS$1.9tUS$43.3b27.2x27.5x0.6x
Thu, 27 Jun 2024US$1.1tUS$1.9tUS$43.4b25.2x25x0.6x
Sat, 25 May 2024US$1.1tUS$1.9tUS$43.3b26.5x25.6x0.6x
Mon, 22 Apr 2024US$1.1tUS$1.9tUS$43.0b25.9x25.9x0.6x
Wed, 20 Mar 2024US$1.1tUS$1.8tUS$49.6b24.4x22.7x0.6x
Fri, 16 Feb 2024US$1.1tUS$1.8tUS$50.5b24x22.6x0.6x
Sun, 14 Jan 2024US$1.2tUS$1.8tUS$50.8b24x22.7x0.6x
Tue, 12 Dec 2023US$1.2tUS$1.8tUS$51.2b23x22.7x0.6x
Thu, 09 Nov 2023US$1.2tUS$1.8tUS$50.6b21.1x22.8x0.6x
Sat, 07 Oct 2023US$1.1tUS$1.8tUS$46.9b22.4x24x0.6x
Mon, 04 Sep 2023US$1.1tUS$1.8tUS$46.7b22.2x23x0.6x
Wed, 02 Aug 2023US$1.1tUS$1.7tUS$48.0b22.9x23.7x0.7x
Fri, 30 Jun 2023US$1.1tUS$1.7tUS$45.8b23.6x23.9x0.6x
Sun, 28 May 2023US$1.1tUS$1.7tUS$45.7b21.6x23.5x0.6x
Tue, 25 Apr 2023US$1.1tUS$1.4tUS$44.3b24.4x24.2x0.7x
Thu, 23 Mar 2023US$1.1tUS$1.4tUS$44.4b22x23.6x0.7x
Sat, 18 Feb 2023US$1.1tUS$1.4tUS$43.5b22.5x26.2x0.8x
Mon, 16 Jan 2023US$1.1tUS$1.4tUS$45.0b21.4x25.2x0.8x
Wed, 14 Dec 2022US$1.2tUS$1.4tUS$44.4b21x27.2x0.9x
Fri, 11 Nov 2022US$1.2tUS$1.4tUS$44.5b20.1x27.4x0.9x
Price to Earnings Ratio

27.4x


Total Market Cap: US$1.2tTotal Earnings: US$44.5bTotal Revenue: US$1.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 23.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the American Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 23.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.61x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 7.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.91%
Healthcare-1.12%
Healthcare Services-6.59%
Healthcare Distributors1.34%
Healthcare Facilities-4.02%
Healthcare Services-7.14%
Managed Healthcare-7.83%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry even though it's trading below its 3-year average PE ratio of 38.3x.
    • Analysts are expecting annual earnings growth of 13.6%, which is higher than its past year's earnings growth of 6.3% per year.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading below its 3-year average of 21.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 29% over the next 5 years.
  • This is better than its past earnings growth rate of 7.5% per year.
  • In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAH Cardinal HealthUS$190.2216.1%
+US$6.3b		70.0%PE28.3x
GH Guardant HealthUS$98.9239.6%
+US$3.6b		319.2%PS13.8x
MCK McKessonUS$820.291.1%
+US$1.1b		56.0%PE32.2x
COR CencoraUS$340.931.5%
+US$946.1m		45.8%PE34.8x
CNC CenteneUS$34.504.1%
+US$676.3m		-45.9%PS0.1x

Latest News

CNC
US$34.50
Centene
7D
4.1%
1Y
-45.9%
CI
US$258.62
Cigna Group
7D
-16.4%
1Y
-17.2%
MD
US$21.08
Pediatrix Medical Group
7D
20.9%
1Y
39.2%
UHS
US$220.70
Universal Health Services
7D
3.1%
1Y
5.7%
WGS
US$138.30
GeneDx Holdings
7D
5.8%
1Y
84.0%
GH
US$98.92
Guardant Health
7D
39.6%
1Y
319.2%

Earnings Update: Guardant Health, Inc. (NASDAQ:GH) Just Reported And Analysts Are Boosting Their Estimates

Nov 02
Earnings Update: Guardant Health, Inc. (NASDAQ:GH) Just Reported And Analysts Are Boosting Their Estimates
LH
US$257.84
Labcorp Holdings
7D
-6.5%
1Y
13.5%
MCK
US$820.29
McKesson
7D
1.1%
1Y
56.0%
HUM
US$279.92
Humana
7D
-4.2%
1Y
9.5%

HUM: Medicare Advantage Stars And ACA Premiums Will Shape Balanced Near-Term Outlook

Humana's analyst price target increased slightly, rising by approximately $0.83 to $295.38. Analysts cite mixed dynamics in Medicare Advantage star ratings and improving earnings visibility as factors supporting cautious optimism.
ELV
US$313.19
Elevance Health
7D
-8.6%
1Y
-25.0%

ELV: Margin Recovery Will Drive Upside Despite ACA Headwinds And Premium Increases

Elevance Health's analyst price target has increased by approximately $14 to $389. Analysts cite firmer profit margin expectations, even though the managed care sector continues to face challenges to revenue growth.
CAH
US$190.22
Cardinal Health
7D
16.1%
1Y
70.0%

CAH: Core Pharmaceutical Trends And Automation Will Shape Upcoming Earnings Performance

Cardinal Health's analyst price target has increased from $180 to $216 per share. This reflects stronger confidence in the company's core pharmaceutical business and its ability to deliver on long-term earnings targets, according to recent analyst commentary following robust quarterly results.
THC
US$201.39
Tenet Healthcare
7D
-6.8%
1Y
24.0%
UNH
US$333.79
UnitedHealth Group
7D
-8.8%
1Y
-40.2%
CVS
US$78.44
CVS Health
7D
-4.9%
1Y
43.5%
HCA
US$461.56
HCA Healthcare
7D
-1.3%
1Y
27.1%

Supplemental Payments And Policy Risks Will Shape Future Performance And Value

HCA Healthcare's fair value estimate has been raised from $417.52 to $471.00. Analysts cite strong quarterly performance, improved profit margins, and the positive impact of supplemental payment approvals as key drivers for the upward revision.
COR
US$340.93
Cencora
7D
1.5%
1Y
45.8%